Management Team

Management Team

Greg Schmergel

Co-Founder and CEO

Greg Schmergel is a serial entrepreneur who has started multiple companies, including Nantero, Inc. (one of the world’s leading nanotechnology companies), ExpertCentral.com, and Tower Group. He serves on multiple Boards including as member of the Board of Trustees of the Lahey Hospital & Medical Center and of the Lahey Clinic Foundation and as a Venture Partner at Rubicon Venture Capital. Before serving as CEO at Nantero, Greg was Senior Vice President, Corporate Strategy for About, Inc., at the time the 5th largest Web property in the world. Previously, he was President and CEO of ExpertCentral.com, Inc.

Greg founded ExpertCentral.com to provide consumers and small businesses with access to thousands of experts to use as an online resource for important questions on a wide variety of topics (later acquired by About, Inc.). Before that, he was a Case Team Leader for Bain & Company and held a senior position at TowerGroup, which he helped start (acquired by Reuters). Greg was a previous Ernst & Young Entrepreneur of the Year Award winner in New England, in the emerging technology category, and was also inducted into Boston Business Journal’s 40-under-40 Hall of Fame in 2018. Greg stays active in supporting the entrepreneurship and business community including being a judge in the Harvard Business School New Venture Competition and at the MassChallenge accelerator, a guest speaker at entrepreneurial classes and groups, a past judge in MIT business plan competitions, and a Board member on the Mass Technology Leadership Council. He holds an AB magna cum laude from Harvard University and an MBA from the Harvard Graduate School of Business Administration.

Keshav K. Singh,PhD

Scientific Founder & Chief Scientific Officer

Dr. Keshav Singh is the Scientific Founder and Chief Scientific Officer of Yuva Biosciences. He is one of the world leaders in the field of mitochondrial biology and genetics and its role in health, disease and aging. Currently, he is the Joy and Bill Harbert Endowed Chair and Director of Cancer Genetics at the University of Alabama at Birmingham. He is also a Professor of Genetics, Pathology and Environmental Health. Besides a mitochondrial role in health and disease, he is an expert in numtogenesis, cancer genetics, and cancer health disparities. He is the founding editor-in-chief of the Mitochondrion journal as well as Cancer Health Disparities.

Dr. Singh has been cited in newspapers, magazine, and has given interviews to radio shows and television about stories of public interest. His research has been highlighted in Nature, Newsweek, US News and World Report, Forbes, Vogue, Bazaar, Beauty Crew, Hindustan Times, International Business Times, Bloomberg and many other news outlets around the world. Dr. Singh founded the Mitochondria Research and Medicine Society in the US and India and is instrumental in promoting understanding and awareness of the mitochondrial diseases around the globe. He has organized numerous scientific meetings and workshops on mitochondria related topics. He has also given many keynote lectures and chaired or co-chaired scientific sessions in national and international professional meetings. Dr. Singh has served or serves on the editorial board of many journals. He is the author of more than a hundred research publications and three books. He has served or serves on expert grants review panels in the United States, Austria, Italy, UK, Poland, Singapore, and other countries. He has won numerous awards.

Dr. Singh did his undergraduate degree in India, Ph.D. in Australia and the postdoctoral studies at Harvard, USA. After completing his postdoctoral studies, he joined John Hopkins as Assistant Professor of Oncology at Johns Hopkins School of Medicine. Prior to moving to University of Alabama at Birmingham (UAB), he was at Roswell Park Cancer Institute in Buffalo NY where he rose through the ranks to Professor and then to Distinguished Professor of Oncology .
Full List of Publications

Saksham Narang

Co-Founder and Vice President

Saksham Narang his career at an investment bank in Boston/Cambridge that provided sophisticated mergers & acquisition guidance and strategic consulting services exclusively to the medical technology and healthcare sectors. He went on to help transition the bank into a first-time venture firm that successfully raised $50M in Fund I. During his time, Saksham helped at all levels of fund management including fundraising, deal sourcing, conducting due diligence, and reporting. After departing Boston/Cambridge to pursue entrepreneurial efforts, Saksham joined the University of Alabama at Birmingham (UAB) as a Venture Advisor in 2018.

At UAB, he assisted faculty and staff in evaluating the commercial potential of their early-stage research. Saksham is now the Vice President of Yuva Biosciences. He also sits on the Board of BIO Alabama, the leading advocacy organization for Alabama’s bioscience community. Saksham received his Bachelor of Science from Boston University in 2015.

Leopoldo Aguilera-Aguirre,PhD

Principal Research Scientist

Leopoldo Aguilera-Aguirre is the Principal Research Scientist at Yuva Biosciences. His research interests include the role of mitochondrial dysfunction in biological processes such as senescence and the decline of normal physiological functions in the organisms leading to age-related manifestations and degenerative diseases in various organs. Oxidative stress plays a critical role in the development of these age-related manifestations. During his doctoral and postdoctoral training, he developed diverse molecular biology skills in cell and animal models applicable to various biological processes including bioenergetics, inflammation, senescence, DNA damage and innate immune responses.

Dr. Aguilera-Aguirre has published scientific articles in multiple recognized international peer-reviewed journals including Nature. He also has served as a reviewer for different scientific journals including Free Radical Biology & Medicine (Elsevier) and PLOS ONE.

Dr. Aguilera-Aguirre joined Yuva Biosciences because he is an enthusiastic scientist devoted to discovering and optimizing the use of natural products to improve the quality of life for persons suffering from age-related disease conditions.